Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Net Income: 2012-2025

Historic Net Income for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $26.5 million.

  • Phibro Animal Health's Net Income rose 280.32% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.1 million, marking a year-over-year increase of 123.38%. This contributed to the annual value of $43.5 million for FY2025, which is 228.61% up from last year.
  • Latest data reveals that Phibro Animal Health reported Net Income of $26.5 million as of Q3 2025, which was up 112.71% from $12.5 million recorded in Q2 2025.
  • Phibro Animal Health's 5-year Net Income high stood at $26.5 million for Q3 2025, and its period low was -$8.0 million during Q3 2023.
  • Its 3-year average for Net Income is $9.3 million, with a median of $8.6 million in 2023.
  • Its Net Income has fluctuated over the past 5 years, first crashed by 307.86% in 2023, then soared by 280.32% in 2025.
  • Over the past 5 years, Phibro Animal Health's Net Income (Quarterly) stood at $17.5 million in 2021, then tumbled by 58.72% to $7.2 million in 2022, then crashed by 82.33% to $1.3 million in 2023, then surged by 150.00% to $3.2 million in 2024, then spiked by 280.32% to $26.5 million in 2025.
  • Its Net Income stands at $26.5 million for Q3 2025, versus $12.5 million for Q2 2025 and $20.9 million for Q1 2025.